Founded more than 30 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California,

Genentech is aggressively researching ADCs and their potential to play an important role in clinical medicine and to expand the therapeutic options available to patients

1 DNA Way
South San Francisco, CA 94080


Advertisement #5
Previous articleF-star
Next articleGlykos
Sonia Portillo
Sonia Portillo is an associate editor of ADC Review | Journal of Antibody-Drug Conjugates, an online, peer reviewed publication dedicated to following the developments of ADCs and other targeted therapies and a contributing editor to Onco'Zine. Portillo studies cancer treatment from a pharmacological perspective, specifically in the area of precision and personalized medicine.